Stem Cell Manufacturing Market To Cross US$ 19.9 Billion by 2028 | IMARC Group

According to IMARC Group's latest report, titled "𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 2023-2028", the stem cell manufacturing market reached US$ 12.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.9 Billion by 2028, exhibiting a CAGR of 8.1% during 2023-2028.

Stem cells represent undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, including red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. Stem cells are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Consequently, they are also utilized to replace damaged organs and tissues and treat numerous diseases.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗯𝗿𝗼𝗰𝗵𝘂𝗿𝗲: https://www.imarcgroup.com/stem-cell-manufacturing-market/requestsample

𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬

The inflating venture capital (VC) investments in stem cell research, on account of the increasing awareness about the therapeutic potency of these cells, are among the key factors stimulating the stem cell manufacturing market. Moreover, the widespread adoption of partially differentiated cells in effective disease management, personalized medicine, and genome testing applications is acting as another significant growth-inducing factor. Besides this, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating several production steps into one device is positively influencing the global market.

Furthermore, the rising utilization of stem cells in the pharmaceutical sector for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is also propelling the market growth. Apart from this, the increasing application of undifferentiated cells in research applications to produce new drugs that aid in improving functions and altering the progress of diseases is further fueling the global market. Additionally, the growing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructures, and the launch of various government initiatives promoting public health are anticipated to fuel the stem cell manufacturing market over the forecasted period.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=6072&method=1

𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 2023-2028 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

The competitive landscape of the stem cell manufacturing market has been studied in the report with the detailed profiles of the key players operating in the market.

𝗦𝗼𝗺𝗲 𝗼𝗳 𝘁𝗵𝗲𝘀𝗲 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:

Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc

𝗞𝗲𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

The report has segmented the stem cell manufacturing market bases on product, application and end user.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭:

𝐂𝐨𝐧𝐬𝐮𝐦𝐚𝐛𝐥𝐞𝐬
Culture Media
Others

𝐈𝐧𝐬𝐭𝐫𝐮𝐦𝐞𝐧𝐭𝐬
Bioreactors and Incubators
Cell Sorters
Others

𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 𝐋𝐢𝐧𝐞𝐬
Hematopoietic Stem Cells (HSC)
Mesenchymal Stem Cells (MSC)
Induced Pluripotent Stem Cells (iPSC)
Embryonic Stem Cells (ESC)
Neural Stem Cells (NSC)
Multipotent Adult Progenitor Stem Cells

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬

Life Science Research
Drug Discovery and Development

𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
Allogenic Stem Cell Therapy
Autologous Stem Cell Therapy
Cell and Tissue Banking Applications

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/stem-cell-manufacturing-market

𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐎𝐭𝐡𝐞𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭-

Global Liquid Fertilizers Market Report- https://www.openpr.com/news/2970672/liquid-fertilizers-market-size-is-projected-to-reach-us-17-06

Global Silicon Fertilizer Market Research Report- https://www.openpr.com/news/2970710/silicon-fertilizer-market-report-2022-size-share-trends

Global Superalloys Market Research Report- https://www.openpr.com/news/2947606/superalloys-market-size-is-projected-to-reach-us-7-8-billion

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 |
Europe & Africa: +44-753-713-2163 |
Asia: +91-120-433-0800

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.